Besides PC, RIPK2 is frequently genetically altered in several other cancers, its overexpression is associated with shorter overall survival in nine cancer types, and its activity scores are highly correlated with MYC activity scores across 32 cancer types. This evidence concerns the gene MYC and cancer.